echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Nature's breakthrough discovery: a unique new mechanism of human short intron splicing

    Nature's breakthrough discovery: a unique new mechanism of human short intron splicing

    • Last Update: 2021-08-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    SPF45 is a new type of essential splicing factor that acts on a subset of human short introns; a new study by researchers at Fujita Health University in Japan shows that the splicing mechanism involving this factor is different from the longer traditional splicing factor.



    Protein coding genes carry the blueprint for protein production


    The length of human pre-mRNA introns varies greatly, ranging from less than 50 nucleotides to more than 1 million nucleotides (nt)


    Now, a research team led by Professor Akila Mayeda of the Institute of Comprehensive Medical Sciences at Fujita Health University in Japan is trying to answer this question in the latest research published in Nature Communications


    The research team first searched for the necessary factors for splicing human short introns from 154 human nucleoproteins


    In HNRNPH1 pre-mRNA with 56-nt intron, the strongest splicing inhibition was caused by SPF45 knockdown, while splicing inhibition was not observed in HNRNPH1 pre-mRNA with control 366-nt intron


    Next, the researchers investigated the factors that determine the spf45 dependence of certain short introns


    Previously, it has been reported that SPF45 acts as a regulator of alternative splicing; however, SPF45 is also an important factor for cell survival and maintenance in vivo


    Professor Mayeda said: "This is a breakthrough achievement in the field of basic research


    Original reference:

    Title of original paper: SPF45/RBM17-dependent, but not U2AF dependent, splicing in a distinct subset of human short introns

    Journal: Nature Communications

    DOI: https://doi.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.